3 completed, 3 recruiting, 2 terminated, 1 active not recruiting. 10 Phase 2, 5 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 3, Recruiting 3, Terminated 2, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 5 | Recruiting 3, Active not recruiting 1, Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Metastatic Malignant Neoplasm in the Lung: new trials by email Literature Review of Metastatic Malignant Neoplasm in the Lung trials Research Report on Metastatic Malignant Neoplasm in the Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies Hafnium Oxide-containing Nanoparticles NBTXR3, Radiation Therapy - Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2023-05-08 | 2026-07-30 |
| Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study Computed Tomography, Indocyanine Green Solution, Therapeutic Bronchoscopy - Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2022-01-26 | 2024-10-23 | |
| Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases Cisplatin, Isolated Chemotherapeutic Lung Perfusion, Metastasectomy - Metastatic Bone Sarcoma, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Recruiting | Roswell Park Cancer Institute | 99 | 2020-07-16 | 2026-08-21 |
| Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Completed | University of Washington | 20 | 2019-01-15 | 2023-12-29 |
| Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Recruiting | Stanford University | 30 | 2018-07-19 | 2026-10-05 |
| Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery Chemotherapy, Laboratory Biomarker Analysis, Metastasectomy - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver | Phase 2 | Terminated | M.D. Anderson Cancer Center | 29 | 2016-09-23 | 2026-02-17 |
| Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma Dinutuximab, Laboratory Biomarker Analysis, Pharmacological Study - Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 41 | 2016-02-04 | 2023-10-26 |
| Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival Stereotactic Body Radiotherapy, Surgery - Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma | Phase 2 / Phase 3 | Completed | NRG Oncology | 129 | 2014-12-24 | 2026-07-10 |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy Doxepin Hydrochloride, Placebo, Quality-of-Life Assessment - Esophageal Carcinoma, Hypopharyngeal Carcinoma | Phase 2 | Terminated | Mayo Clinic | 5 | 2014-04-14 | 2019-10-01 |
| Aerosolized Aldesleukin in Treating Patients With Lung Metastases Aerosolized Aldesleukin, Laboratory Biomarker Analysis - Metastatic Malignant Neoplasm in the Lung, Metastatic Melanoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 70 | 2012-06-28 | 2026-10-15 |
Sarcoma (3) · Carcinoma, Non-Small-Cell Lung (2) · Colorectal Neoplasms (2) · Lung Neoplasms (2) · Osteosarcoma (2) · Bone Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Renal Cell (1) · Esophageal Neoplasms (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Lymphatic Metastasis (1) · Lymphoma (1) · Melanoma (1) · Mesothelioma (1)
Neoplasms (10) · Neoplasms by Site (8) · Neoplasms by Histologic Type (4) · Neoplasms, Connective and Soft Tissue (4) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Colonic Diseases (2)
Metastasectomy (2) · Radiosurgery (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · CTLA-4 Antigen (1) · Cisplatin (1) · Colony-Stimulating Factors (1) · Doxepin (1) · Drug Therapy (1) · Indocyanine Green (1) · Ipilimumab (1) · Nivolumab (1) · Pharmacogenomic Variants (1) · Platinum (1) · Radiation (1) · Radiotherapy (1)
M.D. Anderson Cancer Center (4) · Mayo Clinic (1) · NRG Oncology (1) · National Cancer Institute (NCI) (1) · Roswell Park Cancer Institute (1) · Stanford University (1) · University of Washington (1)
United States (10) · Canada (2) · Australia (1) · New Zealand (1) · Puerto Rico (1) · Saudi Arabia (1) · South Korea (1)
Cristina Rodriguez (1) · David W Rice (1) · Kenneth Seastedt (1) · Najat Daw (1) · Natalie Lui (1) · Pooja Hingorani (1) · Saumil Gandhi, MD (1) · Steven J Chmura (1) · Terence Sio (1) · Yun S Chun (1)
P30CA015083 (1), U10CA180868 (1), U10CA180886 (1)